Core Viewpoint - ShenZhou Cell's stock price showed a slight decline on August 5, closing at 70.15 yuan, indicating a minor drop of 0.01% from the previous trading day [1] Company Overview - ShenZhou Cell is an innovative enterprise focused on the biopharmaceutical sector, primarily engaged in the research and production of recombinant proteins and monoclonal antibodies [1] - The company is headquartered in Beijing and operates within the innovative drugs and biopharmaceuticals segment [1] Stock Performance - On August 5, the stock reached a high of 70.90 yuan and a low of 68.05 yuan, with a total trading volume of 320 million yuan [1] - The net outflow of main funds on August 5 was 37.93 million yuan, with a cumulative net outflow of 197 million yuan over the past five trading days [1] - The current price-to-earnings (P/E) ratio stands at 122.48, while the price-to-book (P/B) ratio is -77.19 [1]
神州细胞股价微跌0.01% 生物制药企业主力资金持续流出